Crystals of HT adducts formed in a couple of days in 25% vol/vol PEG smear medium and 0.1 M Tris pH 8.5 (MeTRaQ-G), in 20% vol/vol PEG 6000, 10% ethylene glycol, 0.1 M magnesium chloride hexahydrate and 0.1 M MES pH 6 (TRaQ-G) and in 20% vol/vol PEG 6000, 0.1 M lithium chloride and 0.1 M sodium citrate pH 4 (TRaQ-G-ctrl)
Initial evaluation should include a detailed assessment of binge eating patterns, frequency, triggers, and associated distress
Quality assurance standards for 503A compounding pharmacies include rigorous testing, sterility verification, and potency analysis to ensure medication safety and efficacy

Pre-Blend Reconstitution Math (12.5/2.5 mg, 15 mg total) Metric Blend composition Value 12.5 mg retatrutide + 2.5 mg cagrilintide Metric BAC water added Value 2.5 mL Metric Concentration Value 5.0 mg/mL retatrutide + 1.0 mg/mL cagrilintide Metric Ratio held constant Value 5:1 (reta : cag) What Each Draw Delivers (12.5/2.5 mg Pre-Blend) Draw Volume 0.20 mL Units 20 units Retatrutide 1.0 mg Cagrilintide 0.2 mg Draw Volume 0.40 mL Units 40 units Retatrutide 2.0 mg Cagrilintide 0.4 mg Draw Volume 0.60 mL Units 60 units Retatrutide 3.0 mg Cagrilintide 0.6 mg Draw Volume 0.80 mL Units 80 units Retatrutide 4.0 mg Cagrilintide 0.8 mg Draw Volume 1.20 mL Units 120 units* Retatrutide 6.0 mg Cagrilintide 1.2 mg Draw Volume 1.60 mL Units 160 units* Retatrutide 8.0 mg Cagrilintide 1.6 mg Draw Volume 2.40 mL Units 240 units* Retatrutide 12.0 mg Cagrilintide 2.4 mg * Volumes above 100 units exceed a standard 1 mL insulin syringe - split into two injections or use a larger syringe